Get the Stockscreener App
136.33
0.24%
-0.33
After Hours:
136.33
Davita Inc stock is traded at $136.33, with a volume of 723.82K.
It is down -0.24% in the last 24 hours and down -3.68% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$136.66
Open:
$137
24h Volume:
723.82K
Relative Volume:
0.84
Market Cap:
$10.29B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
12.69
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-1.58%
1M Performance:
-3.68%
6M Performance:
-17.96%
1Y Performance:
-7.06%
1-Day Range:
$134.81
$137.02
1-Week Range:
$134.81
$140.42
52-Week Range:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
136.33 | 10.47B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
378.65 | 90.61B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
166.26 | 14.99B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.01 | 11.96B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
191.05 | 12.03B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Berkshire Hathaway sells $27.8 million in DaVita shares - Investing.com
Berkshire Hathaway sells $27.8 million in DaVita shares By Investing.com - Investing.com India
DaVita: International Expansion And Buybacks Will Boost Returns (NYSE:DVA) - Seeking Alpha
DaVita to offer $750M of senior notes in private offering - MSN
DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.96% Potential Upside in the Dialysis Market - DirectorsTalk Interviews
Allen learns about dialysis legislation - Statesboro Herald
Ameriprise Financial Inc. Grows Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
DaVita’s SWOT analysis: healthcare giant faces treatment growth hurdles - Investing.com Australia
DaVita’s SWOT analysis: healthcare giant faces treatment growth hurdles By Investing.com - Investing.com Nigeria
DaVita Completes $1 Billion Senior Notes Offering - TipRanks
DaVita Inc. (DVA) Announces $750 Million Senior Notes Offering - GuruFocus
DaVita upsizes senior notes offering to $1 billion By Investing.com - Investing.com South Africa
DaVita launches $750 million senior notes offering By Investing.com - Investing.com South Africa
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering - The Malaysian Reserve
DaVita (DVA) Announces Upsized $1 Billion Senior Notes Offering - GuruFocus
DaVita Upsizes Private Offering to $1 Billion - TipRanks
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering | DVA Stock News - GuruFocus
DaVita upsizes senior notes offering to $1 billion - Investing.com
Davita Inc. Announces Upsize And Pricing Of $1 Billion Senior Notes Offering - marketscreener.com
DaVita Inc. Announces Offering of $750 Million Senior Notes - marketscreener.com
DaVita Begins Private Offering Of $750 Mln Of Senior Notes - Nasdaq
DaVita Announces $750M Senior Notes Offering - TipRanks
DaVita Launches $750 Million Senior Note Offering - marketscreener.com
DaVita launches $750 million senior notes offering - Investing.com Australia
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship | DVA Stock News - GuruFocus
DaVita Inc. Announces Offering of $750 Million Senior Notes | DVA Stock News - GuruFocus
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - PR Newswire
DaVita (DVA) Stock Holds Steady as Truist Securities Lowers Pric - GuruFocus
Truist Adjusts DaVita (DVA) Price Target Downward | DVA Stock Ne - GuruFocus
Cowen cuts DaVita stock price target to $157 from $165 By Investing.com - Investing.com Nigeria
DaVita (DVA) Target Price Reduced by TD Cowen Analyst | DVA Stoc - GuruFocus
Cowen cuts DaVita stock price target to $157 from $165 - Investing.com
TD Cowen Adjusts Price Target on DaVita to $157 From $165, Maintains Hold Rating - marketscreener.com
Warren Buffett Sells $168M in DaVita Inc. (DVA) Shares - MSN
DaVita Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
DaVita’s Earnings Call: Balancing Achievements and Challenges - TipRanks
Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock - Yahoo Finance
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSN
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates - MSN
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Inc. (NYSE:DVA) Q1 2025 Earnings Call Transcript - Insider Monkey
DaVita Inc. (DVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey
DaVita accused of market collusion in class action lawsuit filed by food workers union - The Business Journals
DaVita Inc. to Participate in the Bank of America Securities 202 - GuruFocus
DaVita (DVA) Reports Strong Q1 Revenue | DVA Stock News - GuruFocus
DaVita Outshines Wall Street With First-Quarter Profit Beat - Finimize
DaVita Inc. 1st Quarter 2025 Results | DVA Stock News - GuruFocus
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract - TradingView
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):